5:56 PM
 | 
Apr 05, 2010
 |  BC Extra  |  Financial News

Altheos raises $20M, in-licenses glaucoma compound

Altheos Inc. (South San Francisco, Calif.) raised $20 million in a series A round on Monday and announced a deal with Asahi Kasei Pharma Corp. Asahi granted Altheos exclusive, worldwide rights,...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >